Approach to patients with pseudo-Cushing’s states
Open accessAbstract
The distinction between pseudo-Cushing’s states (PCS) and Cushing’s syndrome (CS) poses a significant clinical challenge even for expert endocrinologists. A patient’s clinical history can sometimes help to distinguish between them (as in the case of alcoholic individuals), but the overlap in clinical and laboratory findings makes it difficult to arrive at a definitive diagnosis. We aim to describe the most common situations that can give rise to a condition resembling overt endogenous hypercortisolism and try to answer questions that physicians often face in clinical practice. It is important to know the relative prevalence of these different situations, bearing in mind that most of the conditions generating PCS are relatively common (such as metabolic syndrome and polycystic ovary syndrome), while CS is rare in the general population. Physicians should consider CS in the presence of additional features. Appropriate treatment of underlying conditions is essential as it can reverse the hormonal abnormalities associated with PCS. Close surveillance and a thorough assessment of a patient’s hormone status will ultimately orient the diagnosis and treatment options over time.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pseudo-Cushing states, such as severe obesity, alcoholism, polycystic ovary syndrome, and neuropsychiatric disorders, are beyond compare more prevalent than endogenous Cushing syndrome.
“These pseudo-Cushing states, such as with severe obesity, alcoholism, polycystic ovary syndrome, and neuropsychiatric disorders, are beyond compare more prevalent than endogenous CS (40) (see also subparagraph “Pseudo-Cushing’s syndrome”).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822 · see citing works
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · see citing works
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715 · see citing works
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · see citing works
Depression and cardiac mortality: results from a community-based longitudinal study.
Penninx, B., Beekman, A., Honig, A., Deeg, D., Schoevers, R., van Eijk, J., & van Tilburg, W. V. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.3.221 · Cited by 983 · see citing works
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833 · see citing works
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775 · see citing works
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592 · see citing works
Björntorp, P. A., & Rosmond, R. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00422-6 · Cited by 584 · see citing works
Rask, E., Walker, B., Söderberg, S., Livingstone, D., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 467 · see citing works
Cortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458 · see citing works
Rodriguez, A. C. I., Epel, E. S., White, M. L., Standen, E. C., Seckl, J. R., & Tomiyama, A. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.014 · Cited by 422 · see citing works
Handelsman, D. J., & Wartofsky, L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3375 · Cited by 368 · see citing works
Pasquali, R., Cantobelli, S., Casimirri, F., Capelli, M., Bortoluzzi, L., Flamia, R., Labate, A. M., & Barbara, L. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.2.8393881 · Cited by 366 · see citing works
Cortisol and depression: three questions for psychiatry
Herbert, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712000955 · Cited by 301 · see citing works
Occult Cushing’s syndrome in type-2 diabetes
Catargi, B., Rigalleau, V., Poussin, A., Ronci-Chaix, N., Bex, V., Vergnot, V., Gin, H., Roger, P., & Tabarin, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030254 · Cited by 287 · see citing works
Resistance to Suppression by Dexamethasone of Plasma 11-O.H.C.S. Levels in Severe Depressive Illness
Carroll, B. J., Martin, F. I. R., & Davies, B. (1968) · BMJ · doi:10.1136/bmj.3.5613.285 · Cited by 279 · see citing works
Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
Papanicolaou, D. A., Mullen, N., Kyrou, I., & Nieman, L. K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020534 · Cited by 241 · see citing works
Abraham, S. B., Rubino, D., Sinaii, N., Ramsey, S., & Nieman, L. K. (2013) · Obesity · doi:10.1002/oby.20083 · Cited by 225 · see citing works
Cortisol Circadian Rhythm Alterations in Psychotic Major Depression
Keller, J., Flores, B., Gomez, R. G., Solvason, H. B., Kenna, H., Williams, G. H., & Schatzberg, A. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.014 · Cited by 217 · see citing works
Twenty-Four-Hour ACTH and Cortisol Pulsatility in Depressed Women
Young, E. A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00236-0 · Cited by 195 · see citing works
Enhanced early morning salivary cortisol in neuroticism.
Portella, M., Harmer, C., Flint, J., Cowen, P., & Goodwin, G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.807 · Cited by 178 · see citing works
Morton, N. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 163 · see citing works
Pasquali, R., Ambrosi, B., Armanini, D., Cavagnini, F., Uberti, E. D., del Rio, G., Pergola, G. D., Maccario, M., Mantero, F., Marugo, M., et al. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.1.8158 · Cited by 149 · see citing works
Vicennati, V., & Pasquali, R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6946 · Cited by 146 · see citing works
Papanicolaou, D., Yanovski, J., Cutler, G., Chrousos, G., & Nieman, L. (1998) · Journal of Clinical Endocrinology and Metabolism · doi:10.1016/s0248-8663(98)80399-8 · Cited by 146 · see citing works
Pecori Giraldi, F., Pivonello, R., Ambrogio, A. G., De Martino, M. C., De Martin, M., Scacchi, M., Colao, A., Toja, P. M., Lombardi, G., & Cavagnini, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02717.x · Cited by 141 · see citing works
Self-citationEffect of age and sex on cortisol secretion in depressives and normals.
Halbreich, U., Asnis, G., Zumoff, B., Nathan, R., & Shindledecker, R. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90037-4 · Cited by 134 · see citing works
Tobias Stalder, A., Kirschbaum, C., Heinze, K., Steudte‐Schmiedgen, S., Foley, P., Tietze, A., & Dettenborn, L. (2010) · Biological Psychology · doi:10.1016/j.biopsycho.2010.08.005 · Cited by 126 · see citing works
Body fat redistribution after weight gain in women with anorexia nervosa.
Mayer, L., Walsh, B., Pierson, R. N., Heymsfield, S., Gallagher, D., Wang, J., Parides, M. K., Leibel, R., Warren, M. P., Killory, E., et al. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.6.1286 · Cited by 126 · see citing works
Antonelli, G., Ceccato, F., Artusi, C., Marinova, M., & Plebani, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.004 · Cited by 111 · see citing works
Kaltsas, G., Korbonits, M., Isidori, A., Webb, J., Trainer, P., Monson, J., Besser, G., & Grossman, A. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01117.x · Cited by 110 · see citing works
Moro, M., Putignano, P., Losa, M., Invitti, C., Maraschini, C., & Cavagnini, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6862 · Cited by 106 · see citing works
Mortola, J. F., LIU, J. H., GILLIN, J. C., Rasmussen, D. D., & Yen, S. S. C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-5-962 · Cited by 105 · see citing works
Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests
Alwani, R. A., Schmit Jongbloed, L. W., de Jong, F. H., van der Lely, A. J., de Herder, W. W., & Feelders, R. A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0702 · Cited by 98 · see citing works
Cushing's Syndrome: Problems in Diagnosis
Aron, D. C., Tyrrell, J., Fitzgerald, P., Findling, J. W., & Forsham, P. (1981) · Medicine · doi:10.1097/00005792-198101000-00003 · Cited by 97 · see citing works
Frias, J., Rodríguez, R., Torres, J. M., Ruiz, E., & Ortega, E. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00702-5 · Cited by 94 · see citing works
Terzolo, M., Reimondo, G., Chiodini, I., Castello, R., Giordano, R., Ciccarelli, E., Limone, P., Crivellaro, C., Martinelli, I., Montini, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1323 · Cited by 89 · see citing works
Tirabassi, G., Faloia, E., Papa, R., Furlani, G., Boscaro, M., & Arnaldi, G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1146 · Cited by 89 · see citing works
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 82 · see citing works
CONNAN, F., LIGHTMAN, S., LANDAU, S., WHEELER, M., TREASURE, J., & CAMPBELL, I. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.12.005 · Cited by 80 · see citing works
Valassi, E., Swearingen, B., Lee, H., Nachtigall, L. B., Donoho, D. A., Klibanski, A., & Biller, B. M. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1500 · Cited by 78 · see citing works
Adipose tissue 11β-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing’s syndrome
Mariniello, B., Ronconi, V., Rilli, S., Bernante, P., Boscaro, M., Mantero, F., & Giacchetti, G. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02228 · Cited by 75 · see citing works
Alcohol-induced pseudo-Cushing's syndrome.
Jeffcoate, W. (1977) · The Lancet · doi:10.1016/0140-6736(93)90434-i · Cited by 72 · see citing works
Martin, N. M., Dhillo, W. S., Banerjee, A., Abdulali, A., Jayasena, C. N., Donaldson, M., Todd, J., & Meeran, K. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2143 · Cited by 72 · see citing works
Cushing’s Syndrome: Screening and Diagnosis
Ceccato, F., & Boscaro, M. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0153-4 · Cited by 70 · see citing works
Cortisol Metabolism in Depressed Patients and Healthy Controls
Römer, B., Lewicka, S., Kopf, D., Lederbogen, F., Hamann, B., Gilles, M., Schilling, C., Onken, V., Frankhauser, P., & Deuschle, M. (2009) · Neuroendocrinology · doi:10.1159/000235904 · Cited by 63 · see citing works
Gatta‐Cherifi, B., Chabre, O., Cortet, C., Martinie, M., Corcuff, J., Roger, P., & Tabarin, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2829 · Cited by 63 · see citing works
Erickson, D. Z., Natt, N., Nippoldt, T. B., Young, W. F., Carpenter, P. C., Petterson, T. M., & Christianson, T. J. H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2662 · Cited by 61 · see citing works
Tirabassi, G., Papa, R., Faloia, E., Boscaro, M., & Arnaldi, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04096.x · Cited by 50 · see citing works
Hypercortisolism in alcohol dependence and its relation to hippocampal volume loss.
Beresford, T., Arciniegas, D., Alfers, J., Clapp, L., Martin, B., Beresford, H. F., Du, Y. P., Liu, D., Shen, D., Davatzikos, C., et al. (2006) · Journal of Studies on Alcohol · doi:10.15288/jsa.2006.67.861 · Cited by 46 · see citing works
Arnaldi, G., Tirabassi, G., Papa, R., Furlani, G., Trementino, L., Cardinaletti, M., Faloia, E., & Boscaro, M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0125 · Cited by 45 · see citing works
Depression and type 2 diabetes: Cortisol pathway implication and investigational needs
Gragnoli, C. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.23012 · Cited by 45 · see citing works
Evaluation of the DDAVP test in the diagnosis of Cushing's Disease
Rollin, G., Costenaro, F., Gerchman, F., Rodrigues, T. D. C., & Czepielewski, M. A. (2014) · Clinical Endocrinology · doi:10.1111/cen.12661 · Cited by 41 · see citing works
Screening for Cushing’s syndrome in obese women with and without polycystic ovary syndrome
Putignano, P., Bertolini, M., Losa, M., & Cavagnini, F. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345217 · Cited by 33 · see citing works
Absence of circadian salivary cortisol rhythm in women with anorexia nervosa.
dos Santos, E., dos Santos, J. D., Ribeiro, R. P., Silva, A., Moreira, A., & de Sá, M. F. S. (2007) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2006.10.011 · Cited by 32 · see citing works
Jimenez, V. A., Helms, C. M., Cornea, A. M., Meshul, C. K., & Grant, K. A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00260 · Cited by 29 · see citing works
Dammann, C., Stapelfeld, C., & Maser, E. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.018 · Cited by 28 · see citing works
Polycystic ovarian syndrome and Cushing's syndrome: a persistent diagnostic quandary
Brzana, J. A., Yedinak, C. G., Hameed, N., Plesiu, A., McCartney, S., & Fleseriu, M. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.12.038 · Cited by 28 · see citing works
Invitti, C., Giraldi, F. P., Dubini, A., Martin, M. D., & Cavagnini, F. (1991) · Acta Endocrinologica · doi:10.1530/acta.0.1250028 · Cited by 26 · see citing works
Arnardóttir, S., & Sigurjonsdottir, H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03961.x · Cited by 23 · see citing works
HPA-axis hyperactivity and mortality in psychotic depressive disorder: Preliminary findings
Coryell, W. H., Fiedorowicz, J. G., Zimmerman, M. A., & Young, E. A. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.005 · Cited by 22 · see citing works
Hawley, J., Owen, L., Debono, M., Newell-Price, J., & Keevil, B. (2018) · Annals of Clinical Biochemistry · doi:10.1177/0004563218766566 · Cited by 19 · see citing works
Pall, M., Lao, M., Patel, S. S., Lee, M. L., Ghods, D. E., Chandler, D. W., & Friedman, T. (2008) · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · doi:10.1055/s-0028-1087186 · Cited by 15 · see citing works
Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice
Zhao, L., Pan, Y., Peng, K., Wang, Z., Li, J., Li, D., Tong, C., Wang, Y., & Liang, G. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0268 · Cited by 12 · see citing works
Μacut, D., Antić, I. B., Nestorov, J. M., Topalović, V., Macut, J. B., Panidis, D., Kotlica, B. K., Papadakis, E. P., Matić, G. M., & Milutinović, D. V. (2014) · HORMONES · doi:10.14310/horm.2002.1526 · Cited by 12 · see citing works
Gonadotropin pulsatility in Cushing's syndrome compared with polycystic ovary syndrome
Penezić, Z., Žarković, M., Vujović, S., Ćirić, J., Beleslin, B. N., Ivović, M., Pokrajac, A., & Drezgić, M. (2005) · Gynecological Endocrinology · doi:10.1080/09513590400027190 · Cited by 10 · see citing works
Coiro, V., Volpi, R., Galli, P., Manfredi, G., Magotti, M. G., Saccani-Jotti, G., & Chiodera, P. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075671 · Cited by 7
Flagged first, then by citations
4 of the 73 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- [11]Vastbinder M Kuindersma M Mulder AH Schuijt MP Mudde AH The influence of oral contraceptives on overnight 1 mg dexamethasone suppression test. Netherlands Journal of Medicine 2016 158– 161. 27185774
- [17]Deuschle M Schweiger U Weber B Gotthardt U Korner A Schmider J Standhardt H Lammers CH Heuser I Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. Journal of Clinical Endocrinology and Metabolism 1997 234– 238. (10.1210/jcem.82.1.3689) 8989265 · DOI · Paper page
- [21]Carroll BJ Use of the dexamethasone suppression test in depression. Journal of Clinical Psychiatry 1982 44– 50. 7174632
- [43]Rosmond R Dallman MF Björntorp P Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine metabolic and hemodynamic abnormalities. Journal of Clinical Endocrinology and Metabolism 1998 1853– 1859. (10.1210/jcem.83.6.4843) 9626108 · DOI
- [53]Besemer F Pereira AM Smit JWA Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse. Netherlands Journal of Medicine 2011 318– 323. 21934176
Cited by
Sorted by citations
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953 · see citing works
“38 Furthermore, concomitant medi cations could result in steroid crossreactivity or otherwise interfere with laboratory test results.”
Self-citationApproach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91 · see citing works
Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 71 · see citing works
“…presenting with mild autonomous cortisol secretion (MACS) and non-neoplastic hypercortisolism (NNH) states (including chronic alcoholism, polycystic ovary syndrome, anorexia nervosa, and psychiatric disorders) [35], resulting in partial clinical and/or biochemical overlap with overt CS [36].”
BackgroundTabarin, A., Assié, G., Barat, P., Bonnet, F., Bonneville, J. F., Borson-Chazot, F., Bouligand, J., Boulin, A., Brue, T., Caron, P., et al. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.02.001 · Cited by 59 · see citing works
Braun, L. T., Vogel, F., Zopp, S., Marchant Seiter, T., Rubinstein, G., Berr, C. M., Künzel, H., Beuschlein, F., & Reincke, M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac379 · Cited by 52 · see citing works
“The low incidence of CS and the clinical overlap with pseudo-Cushing states (9), that is, patients with metabolic syndrome or polycystic ovary syndrome (PCOS) (5), can delay a definitive diagnosis and treatment, resulting in increased morbidity and mortality among patients (10-12).”
The Stress Axis in Obesity and Diabetes Mellitus: An Update
Gianotti, L., Belcastro, S., D’Agnano, S., & Tassone, F. (2021) · Endocrines · doi:10.3390/endocrines2030031 · Cited by 47 · see citing works
Diagnostic workup of Cushing’s syndrome
Balomenaki, M., Margaritopoulos, D., Vassiliadi, D. A., & Tsagarakis, S. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13111 · Cited by 41 · see citing works
Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
Ceccato, F., Barbot, M., Scaroni, C. M., & Boscaro, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01615-3 · Cited by 34 · see citing works
Self-citationCeccato, F., Tizianel, I., Vedolin, C. K., Boscaro, M., Barbot, M., & Scaroni, C. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa564 · Cited by 33 · see citing works
Self-citationMinnetti, M., Hasenmajer, V., Sbardella, E., Angelini, F., Simeoli, C., Paola, N. D., Cozzolino, A., Pivonello, C., de Alcubierre, D., Chiloiro, S., et al. (2022) · medRxiv · doi:10.1101/2022.05.12.22275009 · Cited by 25
“The ICARO questionnaire could therefore be useful during the diagnostic work-up of CS, and perhaps in pseudo-Cushing’s syndrome [46]; in our cohort a cut-off of <14.”
MethodSelf-citationMondin, A., Barbot, M., Voltan, G., Tizianel, I., Vedolin, C. K., Mazzeo, P., Lazzara, M., Boscaro, M., Scaroni, C. M., & Ceccato, F. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02099-z · Cited by 29 · see citing works
“To date, although a skilled application of the dynamic tests can be useful, the gold standard for correctly identifying NNH/pCS patients should still be the reversal of hypercortisolism by treating identifiable causes or the lack of clinical and biochemical progression during an adequate follow-up [2].”
BackgroundSelf-citationA multidisciplinary approach to the management of adrenal incidentaloma
Voltan, G., Boscaro, M., Armanini, D., Scaroni, C. M., & Ceccato, F. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1948327 · Cited by 27 · see citing works
Self-citationHawley, J., Owen, L., Debono, M., Newell-Price, J., & Keevil, B. (2018) · Annals of Clinical Biochemistry · doi:10.1177/0004563218766566 · Cited by 19 · see citing works
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)
Scaroni, C. M., Mondin, A., & Ceccato, F. (2022) · Pituitary · doi:10.1007/s11102-022-01222-2 · Cited by 19 · see citing works
Self-citationSchumacher, M. M., & Santambrogio, J. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050837 · Cited by 24 · see citing works
Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients
Ceccato, F., Lizzul, L., Barbot, M., & Scaroni, C. M. (2020) · Endocrine · doi:10.1007/s12020-020-02392-4 · Cited by 14 · see citing works
Self-citationFlowers, K. C., & Shipman, K. E. (2023) · Diagnostics · doi:10.3390/diagnostics13081415 · Cited by 16 · see citing works
Cyclic Cushing’s Syndrome – A Diagnostic Challenge
Świątkowska−Stodulska, R., Berlińska, A., Stefanska, K. A., Kłosowski, P., & Sworczak, K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.658429 · Cited by 28 · see citing works
“In obesity and PCOS the low-dose overnight DST and/or late-night serumcortisol are the tests of choice (30, 31).”
BackgroundFarinelli, D. G., Oliveira, K. C., Hayashi, L. F., & Kater, C. E. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.09.007 · Cited by 17 · see citing works
Who and how to screen for endogenous hypercortisolism in patients with mood disorders
Ferrante, E., Simeoli, C., Mantovani, G., & Pivonello, R. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02457-5 · Cited by 8 · see citing works
“First-line screening tests (UFC, DST, LNSC) may result abnormal in both CS patients and NNH, such as patients with mood disorders [29].”
InfluentialSelf-citationSubtyping of Cushing’s Syndrome: A Step Ahead
Tizianel, I., Barbot, M., & Ceccato, F. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2299-5065 · Cited by 9 · see citing works
“…(HPA) axis caused by psychological diseases (major depression, eating disorders), metabolic conditions (obesity, polycystic ovary syndrome, poorly controlled diabetes mellitus), as well as physical (starvation/ chronic intense exercise) or chemical (alcohol) stimuli [6, 7].”
BackgroundMaggio, R., Messina, F., D’Arrigo, B., Maccagno, G., Lardo, P., Palmisano, C., Poggi, M., Monti, S., Matarazzo, I., Laghi, A., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873189 · Cited by 10 · see citing works
“Finally, many abusive substances such as nicotine and alcohol are known to perturb HPA axis (20, 21).”
BackgroundSelf-citationCasteràs, A., Fidilio, E., Comas, M., Zabalegui, A., Flores, V., Giralt, M., Troyano, N. D., Ferrer, R., Vilallonga, R., Ciudin, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175146 · Cited by 5 · see citing works
Lam-Chung, C., & Ramos, D. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075785 · Cited by 4 · see citing works
“Global prevalence of type 2 diabetes (T2D) and obesity is becoming more common, and these, in turn, are commonly associated with mild increased cortisol levels (11, 12).”
BackgroundFerraù, F., Alessi, Y., Nista, F., Roux, A., Ferone, D., & Arvat, E. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02537-0 · Cited by 3 · see citing works
“As shown by a prospective study, menstrual irregularity is seen in 70–80% of the female population with CS, with 46% of these patients showing features of PCOS [27 , 28].”
Case report: Pheochromocytoma-induced pseudo-Cushing’s syndrome
Bobrowicz, M., Nagórska, A., Karpiłowska, A., Rosłon, M., Hubska, J., Gładka, A., Toutounchi, S., Koperski, Ł., & Ambroziak, U. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1491873 · Cited by 3 · see citing works
“The mechanisms contributing to overactivation of the HPA axis have been elegantly reviewed by Scaroni et al. (5).”
Minasyan, M., Gamrat-Żmuda, A., Bryk-Wiązania, A. H., Suchy, W., Bogusławska, A., Rzepka, E., Piwońska‐Solska, B., Majka, K., Hubalewska–Dydejczyk, A., Valassi, E., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1785054 · Cited by 2 · see citing works
“Some CS features may overlap with features existing in non-CS patients who have metabolic and cardiovascular comorbidities (1, 9, 10).”
Investigating secondary hypertension in cerebrovascular disease
Zeicu, C., Fisk, M., & Evans, N. R. (2024) · Practical Neurology · doi:10.1136/pn-2024-004169 · Cited by 2 · see citing works
“41”
Park, Y., Gao, F. M., Sim, I., & Gilfillan, C. P. (2023) · JCEM Case Reports · doi:10.1210/jcemcr/luad075 · Cited by 2 · see citing works
Risk Factors Affecting Puberty: Environment, Obesity, and Lifestyles
de Angelis, C., Garifalos, F., Mazzella, M., Menafra, D., Verde, N., Castoro, M., Simeoli, C., Pivonello, C., Colao, A., & Pivonello, R. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-80015-4_10 · Cited by 3 · see citing works
Self-citationCortisol metabolism in obese women with normal and impaired glucose tolerance
Güngör, K. (2021) · The Anatolian Journal of Family Medicine · doi:10.5505/anatoljfm.2021.46036 · Cited by 2
“In fact, it is one of the conditions defined as a pseudo-Cushing syndrome.[7]”
BackgroundA Difficult Case of Ectopic ACTH Syndrome: Is Treatment Possible Even Without Accurate Localization?
Kaplan, A. I., Clifford, L., & Wakil, A. (2025) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.040.02.26 · Cited by 1
Lionetto, L., Bernardini, D. D., Costanzi, G., Maggio, R., Aloini, M. E., Roberto, G., Ricci, F., Biondo, I., Lardo, P., Salerno, G., et al. (2025) · American Journal of Medicine · doi:10.1016/j.amjmed.2025.04.035 · Cited by 1 · see citing works
Self-citationPseudo-Cushing’s state in a patient with non-functioning pituitary adenoma
Yamamoto, K., Hanayama, Y., & Otsuka, F. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-244438 · Cited by 1 · see citing works
Ipercortisolismo funzionale e sue possibili conseguenze cliniche
Martino, M., & Arnaldi, G. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00865-w · Cited by 1 · see citing works
When anorexia nervosa conceals Cushing syndrome: a diagnostic pitfall in hypercortisolemia
Lim, M. Y., Chong, S., & Milner, K. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag309
“Both conditions can present with biochemical hyper-cortisolemia and overlapping clinical features, yet their underlying pathophysiology and management differ substantially [1, 2].”
InfluentialSolitary Fibrous Tumor of the Adrenal Gland: A Comprehensive Review
Vassallo, A., Salvio, G., Martino, M., Ciarloni, A., Valsecchi, F., Balercia, G., & Guazzoni, V. (2026) · Endocrines · doi:10.3390/endocrines7030042
Frias, J. (2026) · Diabetes, obesity and metabolism · doi:10.1111/dom.71163
“The key clinical distinction is that cortisol abnormalities in these states typically resolve when the underlying condition is treated, whereas pathologic hy-percortisolism persists [3, 49].”
Vivekanand, B., Sethi, K., Sharma, E., Soumya, S., & Andrade, C. (2026) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2026.105077
Non-incidentally detected adrenal mass: a paradigm shift beyond incidentaloma?
Dalmazi, G. D., & Ceccato, F. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02914-3
“…in the 143 patients with difficult-to-control T2DM and normal adrenal imaging is food for thought, because it is a manifest case of non-neoplastic hypercortisolism [ 13 ] with the confirma - tion of the absence of an adenoma, nonetheless it is another chapter of patients with cortisol excess.”
Endocrine hypertension in 2025: how AI and multiomics are revolutionizing detection
Fuentes‐Mendoza, J. M., Concepción‐Zavaleta, M. J., Mendoza-Godoy, J. J., Aldave, J. E. Q., Morón-Siguas, J. C., & Paz‐Ibarra, J. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2634025
“…psychiatric disorders, chronic alcoholism, polycystic ovary syndrome, or obesity – second-line tests including the combined dexamethasone – CRH (Dex-CRH) test (and, in selected settings, desmopressin-based approaches) may be used to improve diagnostic discrimination in challenging cases [140,159].”
Erdoğan, B. T., Köroğlu, E. Y., Saçıkara, M., Seyrek, F. N. Ç., Aydın, C., Topaloğlu, O., Ersoy, R., & Çakır, B. (2026) · Diabetes, obesity and metabolism · doi:10.1111/dom.70522
“12 Pharmacokinetic considerations represent another crucial aspect of our findings.”
A Rare Case of Hypercortisolemia Alongside Anorexia Nervosa
Kara, Z., Alay, M., Erbay, M. İ., Uysal, S., & Kadıoğlu, P. (2025) · Cureus · doi:10.7759/cureus.91225
“In PCS, increased secretion of adrenocorticotropic hormone (ACTH) is seen without a tumor source [4].”
Haberbosch, L., Fassnacht, M., Reincke, M., Kabilka, A., Effenberger, T., Hupp, T., Tuckermann, J., Petersenn, S., & Kreitschmann-Andermahr, I. (2025) · Das Gesundheitswesen · doi:10.1055/a-2776-2466
“Da sich die Verände - rungen schleichend entwickeln und unspezifisch sind [13, 14], er - folgt die Diagnose erst Jahre nach Krankheitsbeginn.”
Glucocorticoid Resistance Syndrome as a Hidden Cause of Nonneoplastic Hypercortisolism
Yamamoto, N., Kido, N., Sugawara, K., Bando, H., Yamamoto, M., Urai, S., Tsujimoto, Y., Ohmachi, Y., Motomura, Y., Oi-Yo, Y., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf097
“However, there is still ongoing debate about their ideal cutoff values in various clinical contexts, and none have been established as a benchmark for distinguishing CS from NNH [1, 5, 6].”
InfluentialManagement of Cushing’s disease in the initial phase~From detection to surgery~
Fukuoka, H. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0309
“…results can be caused by non-neoplastic hypercortisolism (NNH), also known as pseudo-Cushing’s syndrome due to depression, obesity, polycystic ovary syndrome (PCOS), poorly controlled diabetes mellitus, chronic alcoholism, chronic kidney disease, and glucocorticoid resistance [56, 57].”
Sanctis, S. A. D., Chiloiro, S., Tanzarella, E., Bongiovanni, F., Giampietro, A., Infante, A., Pascale, G. D., Marinis, L. D., Antonelli, M., Pontecorvi, A., et al. (2025) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303346706250206070813
La sindrome da resistenza generalizzata ai glucocorticoidi
Martino, M., Lopez, C., Sola, C., Ambo, N., Salvio, G., & Parasiliti‐Caprino, M. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01569-1
“…sebbene tutte e tre le forme rispondano adeguatamen-te al DST-8 mg, solo GRS e malattia di Cushing mostrano appropriato incremento di ACTH e cortisolo dopo stimolo con CRH e/o desmopressina, nonché modulabilità della se-crezione di cortisolo in corso di test combinato DST-CRH [6, 11, 14, 15].”
Factitious cushing’s syndrome with unusual presentation: a case report and literature review
Zeer, A. M. M., Noman, M., Zeer, Z. M. M., Attawneh, A., Bairmani, Z. A., Alfroukh, K. M. A., & Oweina, L. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001050 · Cited by 4 · see citing works
“Based on this assumption, late-night salivary cortisol seems better than low-dose dexamethasone or urine-free cortisol in differentiating Cushing from PCS patients([21]).”
BackgroundPossibili errori nella diagnostica della Sindrome di Cushing
Mondin, A., Ceccato, F., Scaroni, C. M., & Voltan, G. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01183-5
“Scaroni C, Albiger NM, Palmieri S et al (2020) Approach to patients with pseudo-Cushing’s states.”
BackgroundInfluentialSelf-citationApproccio al paziente con Pseudo-Cushing
Albiger, N. M. E., Barbot, M., Mondin, A., & Scaroni, C. M. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00906-4
Self-citationRecent developments in the management of Cushing's syndrome.
Galiana, P. A. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endien.2021.01.001
Recent developments in the management of Cushing's syndrome.
Galiana, P. A. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.01.002
Orsini, H., Castellano, V. B. D., Kokubun, H. S., Lopes, K. A. R., & Velho, N. M. R. D. C. (2021) · Journal of Medical Primatology · doi:10.1111/jmp.12514
COEXISTENCE OF PHEOCHROMOCYTOMA AND HYPERCORTISOLEMIA. DIAGNOSTIC DIFFICULTIES
Krzemińska, M., & Kruzel-Piszczek, A. (2023) · Polski Merkuriusz Lekarski · doi:10.36740/merkur202304118
- Authors
- Scaroni, C., Albiger, N. M., Palmieri, S., Iacuaniello, D., Graziadio, C., Damiani, L., Zilio, M., Stigliano, A., Colao, A., Pivonello, R., & _, _.
- Affiliations
- University of Padua (IT)
- University of Milan (IT)
- University of Naples Federico II (IT)
- Sapienza University of Rome (IT)
- University of Ferrara (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- Corresponding author
- Scaroni, Carla
- ORCID
- Venue
- Endocrine Connections
- Publisher
- Bioscientifica
- Published
- 2020-01
- Volume
- 9
- Issue
- 1
- Pages
- R1-R13
- ISSN
- 2049-3614 (ISSN-L)
- PMC
- PMC6993268
- OpenAlex
- W2996241952
- Cited by
- 68
- References
- 73
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 6 · 2023: 13 · 2022: 13 · 2021: 13 · 2020: 2 · 2018: 1
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Endocrine Connections (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
- Keywords
- pseudo-Cushing's syndrome, Cushing's syndrome, endogenous hypercortisolism, differential diagnosis, metabolic syndrome, polycystic ovary syndrome, alcoholism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review